Gabor Maté on ayahuasca and addiction: a real program, not a randomized trial

The Statement

ayahuasca [can] achieve in a few sittings what many years of psychotherapy can only aspire to

Source: Gabor Maté's own site, drgabormate.com (drgabormate.com essay).

Context

Dr. Gabor Maté developed a clinical model that treats addiction as a response to childhood distress and unprocessed emotional pain rather than as a standalone brain disease or a personal choice. Maté documented this framework in his book "In the Realm of Hungry Ghosts: Close Encounters with Addiction" during his clinical work in Vancouver's Downtown Eastside. In 2010, Maté expanded this framework into psychedelic-assisted therapy by partnering with a traditional Peruvian Shipibo ayahuasquero (a traditional Amazonian plant-medicine healer) to conduct multi-day retreats focused on substance dependency. The retreat sessions took place within a Coast Salish First Nations community in British Columbia, Canada. Sponsored by MAPS Canada (the Canadian chapter of the Multidisciplinary Association for Psychedelic Studies), each five-day retreat combined Western group psychotherapy with traditional ayahuasca ceremonies. Participants attended preparation sessions and daytime integration circles alongside nighttime ceremonies to address biographical trauma. Maté became one of the most visible physician-facilitators working with plant medicine in North America. Maté discussed this approach at length on The Tim Ferriss Show (episode #298, released February 20, 2018), explaining how ceremonial plant medicines interact with repressed emotional injuries. Extensive media interest and public curiosity established these Canadian retreats as a central case study in discussions of psychedelic therapy for addictive disorders.

What The Evidence Shows

An observational study conducted in collaboration with the University of Victoria (UVic) and the University of British Columbia (UBC) evaluated participants from the Canadian retreats and documented statistically significant psychological improvements alongside mixed substance use outcomes. Researchers assessed retreat attendees over several months using standardized behavioral and psychiatric scales. The research operated as a naturalistic observational study rather than a randomized controlled trial (RCT), meaning it lacked an active placebo control group to eliminate self-selection bias or non-pharmacological expectation effects. The study recorded statistically significant improvements (p<0.05) in hopefulness, empowerment, mindfulness, and reported quality of life. In substance consumption, participants self-reported reductions in alcohol, tobacco, and cocaine use, with the reduction in cocaine use reaching statistical significance. In contrast, cannabis and opiate use showed no statistically significant decline across the evaluation window. The study reported that all participants described positive and lasting changes from the retreat experience during follow-up interviews. Federal regulatory enforcement ended the Canadian retreats in 2011 when Health Canada informed Maté that ayahuasca contains dimethyltryptamine (DMT), which is scheduled under Canada's Controlled Drugs and Substances Act. Health Canada issued a formal directive warning that further administration of the brew would prompt a referral to the Royal Canadian Mounted Police (RCMP) for criminal investigation. Maté discontinued all retreat operations inside Canada immediately following that notification. Maté detailed clinical cautions on his personal website in an essay titled "Ayahuasca: The Profound Power of an Amazonian Plant." In that text, Maté wrote that the brew puts people in touch with repressed pain and trauma, while urging individuals to approach the preparation with caution and strictly in structured settings. Maté identified clear hazards, including sexual abuse of vulnerable attendees by bad actors, financial exploitation by unscrupulous practitioners, and the emergence of severe psychological distress without adequate grounding support. He observed that physical violence related to ceremonies is exceedingly rare, almost unheard of. Detailed physiological screening and contraindication checks (such as monoamine oxidase inhibitor [MAOI] interactions) remain mandatory before ingestion, as detailed in our ayahuasca safety guide.

Where It Lands

Bottom Line

Documented evidence confirms that Dr. Gabor Maté facilitated retreat-based ayahuasca sessions for addiction and co-authored observational data showing psychological gains, but the intervention lacks verification from randomized controlled trials. The available data from UVic and UBC show measurable improvements in empowerment and cocaine reduction among self-selected individuals. However, an observational design cannot determine whether pharmacological actions, intense group therapy, ceremonial settings, or natural recovery trajectories drove the outcomes. The findings do not establish that ayahuasca provides a reliable treatment across all substance use disorders or serves as a universal alternative to standard psychiatric care. Opiate and cannabis dependencies showed no measurable decline in the observational data, demonstrating clear boundaries to the therapy's measured impact. This experimental approach is not suitable for individuals with active opiate dependency or medical contraindications, who require established medical care. A randomized, double-blind controlled trial demonstrating significant reductions in substance dependence compared to standard clinical protocols would change this evaluation from an observational finding to proven medical evidence. Maté traveled abroad to participate in ayahuasca sessions in jurisdictions where the brew is not prohibited, but available sources confirm no ongoing ownership or direct management of a specific commercial retreat center. Facilities such as Soltara Healing Center have published interviews with Maté and trained staff in his Compassionate Inquiry method, but Soltara remains an independent organization rather than Maté's personal clinic. Readers evaluating international options can review facility standards and screening procedures in our ayahuasca retreat guide. Patients evaluating therapy options should review our ayahuasca clinical guide to verify medical contraindications before considering ceremonial programs.

Frequently asked questions